DK355287A - 2-oxoindolin-1-alkansyre-forbindelser og farmaceutiske praeparater indeholdende disse - Google Patents

2-oxoindolin-1-alkansyre-forbindelser og farmaceutiske praeparater indeholdende disse

Info

Publication number
DK355287A
DK355287A DK355287A DK355287A DK355287A DK 355287 A DK355287 A DK 355287A DK 355287 A DK355287 A DK 355287A DK 355287 A DK355287 A DK 355287A DK 355287 A DK355287 A DK 355287A
Authority
DK
Denmark
Prior art keywords
indoline
oxo
acetic acid
dichlorobenzyl
compounds
Prior art date
Application number
DK355287A
Other languages
English (en)
Other versions
DK355287D0 (da
Inventor
Jr Harry Ralph Howard
Reinhard Sarges
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DK355287D0 publication Critical patent/DK355287D0/da
Publication of DK355287A publication Critical patent/DK355287A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/96—Spiro-condensed ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Ophthalmology & Optometry (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK355287A 1986-07-10 1987-07-09 2-oxoindolin-1-alkansyre-forbindelser og farmaceutiske praeparater indeholdende disse DK355287A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1986/001429 WO1993012786A1 (en) 1986-07-10 1986-07-10 Indolinone derivatives

Publications (2)

Publication Number Publication Date
DK355287D0 DK355287D0 (da) 1987-07-09
DK355287A true DK355287A (da) 1988-04-08

Family

ID=22195566

Family Applications (1)

Application Number Title Priority Date Filing Date
DK355287A DK355287A (da) 1986-07-10 1987-07-09 2-oxoindolin-1-alkansyre-forbindelser og farmaceutiske praeparater indeholdende disse

Country Status (10)

Country Link
EP (1) EP0252713B1 (da)
JP (1) JPH0643393B2 (da)
AT (1) ATE56435T1 (da)
DE (1) DE3764886D1 (da)
DK (1) DK355287A (da)
ES (1) ES2031506T3 (da)
GR (1) GR3000854T3 (da)
IE (1) IE59995B1 (da)
PT (1) PT85294B (da)
WO (1) WO1993012786A1 (da)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5064852A (en) * 1988-12-16 1991-11-12 Pfizer Inc. Indolinone derivatives
JPH04217684A (ja) * 1990-05-30 1992-08-07 Shionogi & Co Ltd アルド−ス還元酵素阻害物質
US6147106A (en) 1997-08-20 2000-11-14 Sugen, Inc. Indolinone combinatorial libraries and related products and methods for the treatment of disease
US5880141A (en) * 1995-06-07 1999-03-09 Sugen, Inc. Benzylidene-Z-indoline compounds for the treatment of disease
US6906093B2 (en) 1995-06-07 2005-06-14 Sugen, Inc. Indolinone combinatorial libraries and related products and methods for the treatment of disease
WO1998024432A2 (en) * 1996-12-05 1998-06-11 Sugen, Inc. Use of indolinone compounds as modulators of protein kinases
US6316429B1 (en) 1997-05-07 2001-11-13 Sugen, Inc. Bicyclic protein kinase inhibitors
US6486185B1 (en) 1997-05-07 2002-11-26 Sugen, Inc. 3-heteroarylidene-2-indolinone protein kinase inhibitors
US6214991B1 (en) 1998-03-31 2001-04-10 The Institute For Pharmaceutical Discovery, Inc. Substituted indolealkanoic acids
US6569868B2 (en) 1998-04-16 2003-05-27 Sugen, Inc. 2-indolinone derivatives as modulators of protein kinase activity
TNSN99224A1 (fr) 1998-12-01 2005-11-10 Inst For Pharm Discovery Inc Methodes de reduction des niveaux de glucose et triglyceride en serum et pour suppression de l'antigenese utilisant les acides la indolealkanoique
JP3663382B2 (ja) 2000-02-15 2005-06-22 スージェン・インコーポレーテッド ピロール置換２−インドリノン蛋白質キナーゼ阻害剤
MY128450A (en) 2000-05-24 2007-02-28 Upjohn Co 1-(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
JP2003535847A (ja) 2000-06-02 2003-12-02 スージェン・インコーポレーテッド 蛋白質キナーゼ／ホスファターゼ阻害剤としてのインドリノン誘導体
AR042586A1 (es) 2001-02-15 2005-06-29 Sugen Inc 3-(4-amidopirrol-2-ilmetiliden)-2-indolinona como inhibidores de la protein quinasa; sus composiciones farmaceuticas; un metodo para la modulacion de la actividad catalitica de la proteinquinasa; un metodo para tratar o prevenir una afeccion relacionada con la proteinquinasa
US6599902B2 (en) 2001-05-30 2003-07-29 Sugen, Inc. 5-aralkysufonyl-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives as kinase inhibitors
BR0213185A (pt) 2001-10-10 2004-09-14 Sugen Inc Derivados de 3-[4-(heterociclila substituìda)-pirrol-2-ilmetilideno]2-indolinona como inibidores de cinase
DE10210195B4 (de) 2002-03-07 2005-12-15 Schwarz Pharma Ag Verwendung von 1,3-Diazaspiro-[4,5]decan-2,4-dithion zur Behandlung von Schmerz
GB0324763D0 (en) 2003-10-23 2003-11-26 Oxagen Ltd Use of compounds in therapy
US7659300B2 (en) * 2004-09-08 2010-02-09 Merck Sharp & Dohme Corp. Monocyclic anilide spirolactam CGRP receptor antagonists
WO2006105795A1 (en) * 2005-04-08 2006-10-12 Leo Pharma A/S Novel indolinone derivatives
AR053710A1 (es) 2005-04-11 2007-05-16 Xenon Pharmaceuticals Inc Compuestos espiroheterociclicos y sus usos como agentes terapeuticos
AR056968A1 (es) 2005-04-11 2007-11-07 Xenon Pharmaceuticals Inc Compuestos espiro-oxindol y composiciones farmacéuticas
WO2008060789A2 (en) 2006-10-12 2008-05-22 Xenon Pharmaceuticals Inc. Use of spiro-oxindole compounds as therapeutic agents
JO3032B1 (ar) 2008-10-17 2016-09-05 Xenon Pharmaceuticals Inc مركبات سبيرو – اوكسندول وإستعمالاتها كعوامل علاجية.
CA2741024A1 (en) 2008-10-17 2010-04-22 Xenon Pharmaceuticals Inc. Spiro-oxindole compounds and their use as therapeutic agents
AR077252A1 (es) 2009-06-29 2011-08-10 Xenon Pharmaceuticals Inc Enantiomeros de compuestos de espirooxindol y sus usos como agentes terapeuticos
KR20120099429A (ko) 2009-10-14 2012-09-10 제논 파마슈티칼스 인크. 스피로-옥스인돌 화합물의 합성 방법
WO2011106729A2 (en) 2010-02-26 2011-09-01 Xenon Pharmaceuticals Inc. Pharmaceutical compositions of spiro-oxindole compound for topical administration and their use as therapeutic agents
GB201322273D0 (en) 2013-12-17 2014-01-29 Atopix Therapeutics Ltd Process
WO2016127068A1 (en) 2015-02-05 2016-08-11 Teva Pharmaceuticals International Gmbh Methods of treating postherpetic neuralgia with a topical formulation of a spiro-oxindole compound
TW202502735A (zh) * 2023-03-02 2025-01-16 印度商吉德斯生命科學有限公司 新穎atx抑制劑

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3393208A (en) * 1965-10-22 1968-07-16 Mcneilab Inc 6h-benzo[5, 6] cyclohept[1, 2, 3-cd]indolin-1, 6-diones
US3821383A (en) * 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications
US4053613A (en) * 1975-09-17 1977-10-11 E. R. Squibb & Sons, Inc. 1,3,thiazolinyl and 1,3 thiazinyl substituted indolinones
FR2355006A1 (fr) * 1976-06-17 1978-01-13 Labaz Nouveaux derives d'indole et procedes pour les preparer
EP0022317B1 (en) * 1979-06-12 1983-09-21 Fujisawa Pharmaceutical Co., Ltd. 2-oxo-benzothiazoline, benzoxazoline or indoline derivatives, their preparation, and pharmaceutical compositions comprising such derivatives

Also Published As

Publication number Publication date
EP0252713A1 (en) 1988-01-13
ATE56435T1 (de) 1990-09-15
ES2031506T3 (es) 1992-12-16
EP0252713B1 (en) 1990-09-12
PT85294B (pt) 1990-04-30
DE3764886D1 (de) 1990-10-18
JPS6323863A (ja) 1988-02-01
DK355287D0 (da) 1987-07-09
IE871843L (en) 1988-01-10
WO1993012786A1 (en) 1993-07-08
IE59995B1 (en) 1994-05-18
GR3000854T3 (en) 1991-11-15
JPH0643393B2 (ja) 1994-06-08
PT85294A (en) 1987-08-01

Similar Documents

Publication Publication Date Title
DK355287D0 (da) 2-oxoindolin-1-alkansyre-forbindelser og farmaceutiske praeparater indeholdende disse
UA41901C2 (uk) Сіль малеїнової кислоти 5-[4-[2-(n-метил-n-(2-піридил)аміно)етокси]бензил]тіазолідин-2, 4-діону або її таутомерна форма і/або її фармацевтично прийнятний сольват, спосіб її одержання, фармацевтична композиція і спосіб лікування і/або профілактики гіперглікемії, гіперліпідемії, гіпертонії, серцево-судинних захворювань і деяких захворювань, пов'язаних з вживанням їжі.
ATE121743T1 (de) Pyridazinon-derivate.
DK0615549T3 (da) Fremgangsmåde til fremstilling af farmaceutisk aktive thiazolidin- eller oxazolidinforbindelser med en gærreduktase
HU9303009D0 (en) New 2-saccharinyl-methyl-aryl-carboxylat derivatives and pharmaceutical preparations containing said compounds
NO174851C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktiv hydroksyalkylfuranylderivater
DK147588D0 (da) Benzoxazinderivat samt fremgangsmaade til fremstilling deraf
DK561487A (da) 4-phenylsulfonyl-3,4-dihydro-2(1h)-quinoxalinon-1-alkansyre-forbindelser og farmaceutiske praeparater indeholdende disse
IE801005L (en) Benzimidazolones.
NO178025C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive (benzhydryloksyetylpiperidyl)alifatiske syrederivater
KR920007999A (ko) 4-또는 5-치환된 피리딘-2-카복실산. 이들의 제조방법 및 약제로서 이들의 용도
DK240889A (da) S-enantiomere glutaramidderivater og deres anvendelse som laegemidler samt farmaceutiske praeparater indeholdende disse forbindelser
KR910000637A (ko) 피롤 유도체, 이의 제조 방법 및 약제학적 활성화합물로서의 이의 용도
NO893167D0 (no) Nye 6-fluor-3,5-dihydroksykarboksylsyrer og deres derivater samt fremgangsmaater for fremstilling derav.
FI895568A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten aminodiolijohdannaisten valmistamiseksi
FI903626A0 (fi) Menetelmä terapeuttisesti käyttökelpoisen 1H-indatsoli-3-etikkahappojohdannaisen valmistamiseksi
DE3775526D1 (de) Bakterizide pyridobenzothiazinderivate mit langer wirkungsdauer.
DK424888D0 (da) Naphthothiazepinderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende saadanne derivater
FI890929A0 (fi) Foerfarande foer framstaellning av ftalazinaettiksyraesterderivat och ny mellanprodukt.
DE69011174D1 (de) Catecholaminester.
FI895795A0 (fi) Menetelmä optisesti aktiivisten 2-oksoimidatsolidiinijohdannaisten valmistamiseksi
GB1471546A (en) 1-acyl-4-substituted alkyl-piperazine or homopiperazine derivatives nad process for preparation thereof

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment